Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43

Cardiovascular Research

Volumn 109, Issue 3, 2016, Pages 385-396

  Morel, Sandrine ^a   Christoffersen, Christina ^b,c   Axelsen, Lene N ^c,d   Montecucco, Fabrizio ^a   Rochemont, Viviane ^a   Frias, Miguel A ^a   Mach, Francois ^a   James, Richard W ^a   Naus, Christian C ^e   Chanson, Marc ^a   Lampe, Paul D ^f   Nielsen, Morten S ^c,d   Nielsen, Lars B ^b,c,g   Kwak, Brenda R ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c Department of Biomedical Sciences ^*  (Denmark)

^d DANISH NATIONAL RESEARCH FOUNDATION   (Denmark)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f Fred Hutchinson Cancer Research Center   (United States)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Connexin43; Ischaemia reperfusion injury; Sphingosine 1 phosphate

Indexed keywords

CONNEXIN 43; SPHINGOSINE 1 PHOSPHATE; TROPONIN I; APOLIPOPROTEIN; APOLIPOPROTEIN M, MOUSE; CARDIOTONIC AGENT; GAP JUNCTION PROTEIN; HIGH DENSITY LIPOPROTEIN; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1-PHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL INFILTRATION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; TRANSGENIC MOUSE; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CARDIAC MUSCLE CELL; DRUG EFFECTS; GENETICS; HEART MUSCLE ISCHEMIA; KNOCKOUT MOUSE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEINS; CARDIOTONIC AGENTS; CONNEXIN 43; CONNEXINS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MICE, KNOCKOUT; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PHOSPHORYLATION; RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84959922603     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvw004     Document Type: Article

References (44)

1. Sluijter JP, Condorelli G, Davidson SM, Engel FB, Ferdinandy P, Hausenloy DJ, Lecour S, Madonna R, Ovize M, Ruiz-Meana M, Schulz R, Van Laake LW. Novel therapeutic strategies for cardioprotection. Pharmacol Ther 2014;144: 60-70.
2. James RW, Frias MA. High density lipoproteins and ischemia reperfusion injury: the therapeutic potential of HDL to modulate cell survival pathways. Adv Exp Med Biol 2014;824: 19-26.
3. Waeber C, Walther T. Sphingosine-1-phosphate as a potential target for the treatment of myocardial infarction. Circ J 2014;78: 795-802.
4. Karliner JS. Sphingosine kinase and sphingosine 1-phosphate in the heart: A decade of progress. Biochim Biophys Acta 2013;1831: 203-212.
5. Somers SJ, Frias M, Lacerda L, Opie LH, Lecour S. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc Drugs Ther 2012;26: 227-237.
6. Morel S, Frias MA, Rosker C, JamesRW, Rohr S, Kwak BR. The natural cardioprotective particle HDL modulates connexin43 gap junction channels. Cardiovasc Res 2012;93: 41-49.
7. Lampe PD, Lau AF. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 2004;36: 1171-1186.
8. Kanno S, Kovacs A, Yamada KA, Saffitz JE. Connexin43 as a determinant of myocardial infarct size following coronary occlusion in mice. J Am Coll Cardiol 2003;41: 681-686.
9. Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M. Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion. Cardiovasc Res 2004;61: 386-401.
10. Schulz R, Heusch G. Connexin43 and ischemic preconditioning. Adv Cardiol 2006;42: 213-227.
11. Heusch G, Buchert A, Feldhaus S, Schulz R. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 2006;101: 354-356.
12. Skyschally A, Walter B, Schultz Hansen R, Heusch G. The antiarrhythmic dipeptide ZP1609 (danegaptide) when given at reperfusion reduces myocardial infarct size in pigs. Naunyn Schmiedebergs Arch Pharmacol 2013;386: 383-391.
13. Wu Y, Gu EW, Zhu Y, Zhang L, Liu XQ, Fang WP. Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43. Int Immunopharmacol 2012;13: 341-346.
14. Christoffersen C, Jauhiainen M, Moser M, Porse B, Ehnholm C, Boesl M, Dahlback B, Nielsen LB. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J Biol Chem 2008;283: 1839-1847.
15. Maass K, Ghanem A, Kim JS, Saathoff M, Urschel S, Kirfel G, Grummer R, Kretz M, Lewalter T, Tiemann K, Winterhager E, Herzog V, Willecke K. Defective epidermal barrier in neonatal mice lacking the C-terminal region of connexin43. Mol Biol Cell 2004;15: 4597-4608.
16. Huang GY, Xie LJ, Linask KL, Zhang C, Zhao XQ, Yang Y, Zhou GM, Wu YJ, Marquez-Rosado L, McElhinney DB, Goldmuntz E, Liu C, Lampe PD, Chatterjee B, Lo CW. Evaluating the role of connexin43 in congenital heart disease: screening for mutations in patients with outflow tract anomalies and the analysis of knock-in mouse models. J Cardiovasc Dis Res 2011;2: 206-212.
17. Morel S, Braunersreuther V, Chanson M, Bouis D, Rochemont V, Foglia B, Pelli G, Sutter E, Pinsky DJ, Mach F, Kwak BR. Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in mice. Cardiovasc Res 2014;102: 329-337.
18. Olsen KB, Axelsen LN, Braunstein TH, Sorensen CM, Andersen CB, Ploug T, Holstein-Rathlou NH, Nielsen MS. Myocardial impulse propagation is impaired in right ventricular tissue of Zucker diabetic fatty (ZDF) rats. Cardiovasc Diabetol 2013;12: 19.
19. Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnstrom J, Sevvana M, Egerer-Sieber C, Muller YA, Hla T, Nielsen LB, Dahlback B. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci USA 2011;108: 9613-9618.
20. Morel S, Chanson M, Nguyen TD, Glass AM, Richani Sarieddine MZ, Meens MJ, Burnier L, Kwak BR, Taffet SM. Titration of the gap junction protein Connexin43 reduces atherogenesis. Thromb Haemost 2014;112: 390-401.
21. English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JG. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J 2000;14: 2255-2265.
22. Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, Xu Y, Camerer E, Zheng YW, Huang Y, Cyster JG, Coughlin SR. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 2007;316: 295-298.
23. Poti F, Simoni M, Nofer JR. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P). Cardiovasc Res 2014;103: 395-404.
24. Yan X, Anzai A, Katsumata Y, Matsuhashi T, Ito K, Endo J, Yamamoto T, Takeshima A, Shinmura K, Shen W, Fukuda K, Sano M. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol 2013;62: 24-35.
25. Tao R, Hoover HE, Honbo N, Kalinowski M, Alano CC, Karliner JS, Raffai R. Highdensity lipoprotein determines adult mouse cardiomyocyte fate after hypoxiareoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol 2010;298: H1022-H1028.
26. Frias MA, Lang U, Gerber-Wicht C, James RW. Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis. Cardiovasc Res 2010;85: 118-126.
27. Kawabori M, Kacimi R, Karliner JS, Yenari MA. Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets. World J Cardiol 2013;5: 75-86.
28. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I, Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R, Schulz R, Heusch G, Haude M, von Wnuck Lipinski K, Herzog C, Schmitz M, Erbel R, Chun J, Levkau B. Highdensity lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006;114: 1403-1409.
29. Means CK, Xiao CY, Li Z, Zhang T, Omens JH, Ishii I, Chun J, Brown JH. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2007;292: H2944-H2951.
30. Kwak BR, van Veen TA, Analbers LJ, Jongsma HJ. TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels. Exp Cell Res 1995;220: 456-463.
31. Kwak BR, Hermans MM, De Jonge HR, Lohmann SM, Jongsma HJ, Chanson M. Differential regulation of distinct types of gap junction channels by similar phosphorylating conditions. Mol Biol Cell 1995;6: 1707-1719.
32. Ek-Vitorin JF, King TJ, Heyman NS, Lampe PD, Burt JM. Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation. Circ Res 2006; 98: 1498-1505.
33. Lampe PD, TenBroek EM, Burt JM, Kurata WE, Johnson RG, Lau AF. Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol 2000;149: 1503-1512.
34. Bao X, Reuss L, Altenberg GA. Regulation of purified and reconstituted connexin 43 hemichannels by protein kinase C-mediated phosphorylation of Serine 368. J Biol Chem 2004;279: 20058-20066.
35. Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 1996;93: 1831-1835.
36. Ruiz-Meana M, Rodriguez-Sinovas A, Cabestrero A, Boengler K, Heusch G, Garcia-Dorado D. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury. Cardiovasc Res 2008;77: 325-333.
37. Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, Konietzka I, Lopez-Iglesias C, Garcia-Dorado D, Di Lisa F, Heusch G, Schulz R. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 2005;67: 234-244.
38. Boengler K, Ruiz-Meana M, Gent S, Ungefug E, Soetkamp D, Miro-Casas E, Cabestrero A, Fernandez-Sanz C, Semenzato M, Di Lisa F, Rohrbach S, Garcia-Dorado D, Heusch G, Schulz R. Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption. J Cell Mol Med 2012;16: 1649-1655.
39. Ruiz-Meana M, Nunez E, Miro-Casas E, Martinez-Acedo P, Barba I, Rodriguez-Sinovas-A, Inserte J, Fernandez-Sanz C, Hernando V, Vazquez J, Garcia-Dorado D. Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol. J Mol Cell Cardiol 2014;68: 79-88.
40. Miro-Casas E, Ruiz-Meana M, Agullo E, Stahlhofen S, Rodriguez-Sinovas A, Cabestrero A, Jorge I, Torre I, Vazquez J, Boengler K, Schulz R, Heusch G, Garcia-Dorado D. Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake. Cardiovasc Res 2009;83: 747-756.
41. Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, Garcia-Dorado D, Di Lisa F, Schulz R, Heusch G. Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 2005;97: 583-586.
42. Azarashvili T, Baburina Y, Grachev D, Krestinina O, Evtodienko Y, Stricker R, Reiser G. Calcium-induced permeability transition in rat brain mitochondria is promoted by carbenoxolone through targeting connexin43. Am J Physiol Cell Physiol 2011;300: C707-C720.
43. SrisakuldeeW, Makazan Z, Nickel BE, Zhang F, Thliveris JA, Pasumarthi KB, Kardami E. The FGF-2-triggered protection of cardiac subsarcolemmal mitochondria from calcium overload is mitochondrial connexin 43-dependent. Cardiovasc Res 2014;103: 72-80.
44. Maass K, Shibayama J, Chase SE, Willecke K, Delmar M. C-terminal truncation of connexin43 changes number, size, and localization of cardiac gap junction plaques. Circulation Research 2007;101: 1283-1291.